What is Hyperlipidemia?

Hyperlipidemia, hyperlipoproteinemia, dyslipidemia or hyperlipidaemia (British English) is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.

Lipid and lipoprotein abnormalities are extremely common in the general population, and are regarded as a highly modifiable risk factor for cardiovascular disease due to the influence of cholesterol, one of the most clinically relevant lipid substances, on atherosclerosis. In addition, some forms may predispose to acute pancreatitis.

Hyperlipidemias are classified according to the Fredrickson classification which is based on the pattern of lipoproteins on electrophoresis or ultracentrifugation. It was later adopted by the World Health Organization (WHO). It does not directly account for HDL, and it does not distinguish among the different genes that may be partially responsible for some of these conditions. It remains a popular system of classification, but is considered dated by many.

Fredrickson classification of Hyperlipidemias
HyperlipoproteinemiaSynonymsDefectIncreased lipoproteinTreatmentSerum appearance
Type I (rare)''Buerger-Gruetz syndrome'', ''Primary hyperlipoproteinaemia'', or ''Familial hyperchylomicronemia''Decreased lipoprotein lipase (LPL) or altered ApoC2ChylomicronsDiet controlCreamy top layer
Type IIa''Polygenic hypercholesterolaemia'' or ''Familial hypercholesterolemia''LDL receptor deficiencyLDLBile acid sequestrants, statins, niacinClear
Type IIb''Combined hyperlipidemia''Decreased LDL receptor and increased ApoBLDL and VLDLStatins, niacin, fibrateClear
Type III (rare)''Familial dysbetalipoproteinemia''Defect in Apo E 2 synthesisIDLFibrates, statinsTurbid
Type IV''Familial hyperlipemia''Increased VLDL production and Decreased eliminationVLDLFibrate, niacin], statinsTurbid
Type V (rare)''Endogenous hypertriglyceridemia''Increased VLDL production and Decreased LPLVLDL and ChylomicronsNiacin, fibrateCreamy top layer & turbid bottom

Hyperlipoproteinemia type I

Type I hyperlipoproteinemia''' is a form of hyperlipoproteinemia associated with deficiencies of lipoprotein lipase.

Hyperlipoproteinemia type II

Hyperlipoproteinemia type II, by far the most common form, is further classified into type IIa and type IIb, depending mainly on whether there is elevation in the triglyceride level in addition to LDL cholesterol.

Type IIa

This may be sporadic (due to dietary factors), polygenic, or truly familial as a result of a mutation either in the LDL receptor gene on chromosome 19 (0.2% of the population) or the ApoB gene (0.2%). The familial form is characterized by tendon xanthoma, xanthelasma and premature cardiovascular disease. The incidence of this disease is about 1 in 500 for heterozygotes, and 1 in 1,000,000 for homozygotes.

Type IIb

The high VLDL levels are due to overproduction of substrates, including triglycerides, acetyl CoA, and an increase in B-100 synthesis. They may also be caused by the decreased clearance of LDL. Prevalence in the population is 10%.

  • Familial combined hyperlipoproteinemia (FCH)
  • Secondary combined hyperlipoproteinemia (usually in the context of metabolic syndrome, for which it is a diagnostic criterion)

Hyperlipoproteinemia type III

This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as ''broad beta disease'' or ''dysbetalipoproteinemia'', the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL (β-VLDL). Prevalence is 0.02% of the population.

Hyperlipoproteinemia type IV

This form is due to high triglycerides. It is also known as ''hypertriglyceridemia'' (or ''pure hypertriglyceridemia''). According to the NCEP-ATPIII definition of high triglycerides (>200 mg/dl),

prevalence is about 16% of adult population.

Hyperlipoproteinemia type V

This type is very similar to type I, but with high VLDL in addition to chylomicrons.

It is also associated with glucose intolerance and hyperuricemia

Non-classified forms are extremely rare:

  • Hypo-alpha lipoproteinemia
  • Hypo-beta lipoproteinemia (prevalence 0.01-0.1%)

Further Reading

This article is licensed under the Creative Commons Attribution-ShareAlike License. It uses material from the Wikipedia article on "Hyperlipidemia" All material adapted used from Wikipedia is available under the terms of the Creative Commons Attribution-ShareAlike License. Wikipedia® itself is a registered trademark of the Wikimedia Foundation, Inc.

Last Updated: Feb 1, 2011

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | العربية | Dansk | Nederlands | Finnish | Ελληνικά | עִבְרִית | हिन्दी | Bahasa | Norsk | Русский | Svenska | Magyar | Polski | Română | Türkçe
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment